- Home
- IZM vs GOVX Comparison
IZM vs GOVX Comparison
Compare IZM & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- GOVX
- Stock Information
- Founded
- IZM 2011
- GOVX 2001
- Country
- IZM China
- GOVX United States
- Employees
- IZM N/A
- GOVX N/A
- Industry
- IZM Consumer Electronics/Video Chains
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- GOVX Health Care
- Exchange
- IZM Nasdaq
- GOVX Nasdaq
- Market Cap
- IZM 16.6M
- GOVX 16.8M
- IPO Year
- IZM 2023
- GOVX N/A
- Fundamental
- Price
- IZM $0.98
- GOVX $0.42
- Analyst Decision
- IZM
- GOVX Strong Buy
- Analyst Count
- IZM 0
- GOVX 2
- Target Price
- IZM N/A
- GOVX $7.00
- AVG Volume (30 Days)
- IZM 652.3K
- GOVX 535.0K
- Earning Date
- IZM 10-24-2025
- GOVX 11-13-2025
- Dividend Yield
- IZM N/A
- GOVX N/A
- EPS Growth
- IZM N/A
- GOVX N/A
- EPS
- IZM 0.10
- GOVX N/A
- Revenue
- IZM $187,048,691.00
- GOVX $3,353,560.00
- Revenue This Year
- IZM N/A
- GOVX N/A
- Revenue Next Year
- IZM N/A
- GOVX N/A
- P/E Ratio
- IZM $9.65
- GOVX N/A
- Revenue Growth
- IZM 5.12
- GOVX 8.52
- 52 Week Low
- IZM $0.92
- GOVX $0.40
- 52 Week High
- IZM $2.74
- GOVX $3.15
- Technical
- Relative Strength Index (RSI)
- IZM 25.83
- GOVX 30.40
- Support Level
- IZM $0.92
- GOVX $0.46
- Resistance Level
- IZM $1.44
- GOVX $0.52
- Average True Range (ATR)
- IZM 0.18
- GOVX 0.04
- MACD
- IZM -0.03
- GOVX -0.01
- Stochastic Oscillator
- IZM 7.20
- GOVX 12.92
About IZM ICZOOM Group Inc.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.